Deutsche Märkte geschlossen

Mentice AB (publ) (MN2.F)

Frankfurt - Frankfurt Verzögerter Preis. Währung in EUR
Zur Watchlist hinzufügen
2,6000-0,0600 (-2,26%)
Ab 08:24AM CEST. Markt geöffnet.

Mentice AB (publ)

Odinsgatan 10
Gothenburg 411 03
Sweden
46 20 38 85 16 01
https://www.mentice.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter122

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Göran MalmbergGroup CEO & President4,46MN/A1959
Ms. Ulrika Drotz VokseppChief Financial OfficerN/AN/AN/A
Mr. Jonatan SjostromChief Operating OfficerN/AN/AN/A
Mr. Henrik StormChief Technology OfficerN/AN/A1972
Mr. Martin HarrisVice President of Marketing & Sales EnablementN/AN/AN/A
Mr. Matar DakhilExecutive Vice President of Business DevelopmentN/AN/A1964
Ms. Stacy HammarCorporate Marketing Manager of Medical DeviceN/AN/AN/A
Dominic SteffelSenior Product ManagerN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2021 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Mentice AB (publ) provides endovascular simulation technology solutions in Europe, the Middle East, and Africa; Asia and the Asia Pacific region; and the Americas. The company operates through three segments: Systems, Software Licenses and Service. It offers software modules in the areas of acute ischemic stroke intervention, atrial septal defect and patent foramen ovale occlusion, aortic valve implantation, endovascular aortic repair, below-the-knee intervention, carotid intervention, patient-specific simulation, coronary advanced, essential, and intermediate, left atrial appendage occlusion, neurovascular coiling and thrombectomy, peripheral angiography, prostatic artery embolization, radiation safety, renal denervation, renal intervention, thoracic endovascular aortic repair, transarterial chemoembolization, transseptal puncture, uterine artery embolization, peripheral angiography, and vascular trauma and cardiac rhythm management, as well as supports interventionalists to transition from transfemoral to transradial access. The company also provides simulator accessories and extensions for endovascular therapies; cardiovascular; neurovascular; peripheral vascular solutions; mentice right heart cath app, a mobile solution for an interactive real-time exploration into the right heart catheterization procedure; mentice live learning center, a cloud based learning center for medical technology industry and healthcare provider; and angio suites and robotic integrators. Mentice AB (publ) was incorporated in 1998 and is headquartered in Gothenburg, Sweden.

Corporate Governance

Mentice AB (publ)s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.